BioSpace News Archive

Business

Epigenomics AG Reports Results for Financial Year 2018

Epigenomics AG announced the financial results for the year ended December 31, 2018.

March 28, 2019
·
5 min read
Business

GeoVax Reports 2018 Year-End Financial Results

GeoVax Labs, Inc., a biotechnology company developing human vaccines, announced its financial results for the year ended December 31, 2018.

March 28, 2019
·
2 min read
Business

Aveo Oncology Stock Spikes on Rumors of AstraZeneca Acquisition

The rumors speculated that AstraZeneca planned to acquire Aveo in the second quarter of this year in order to gain the company’s kidney cancer drug, Tivozanib.

March 28, 2019
·
2 min read
·
Alex Keown
Policy

Nearly 8,000 Packets of Orkambi Destroyed as the U.K. and Vertex Hash out Pricing Concerns

Cystic fibrosis drugmaker Vertex was forced to destroy nearly 8,000 packs of its drug Orkambi after the medication had expired before they could be shipped to the United Kingdom due to a contentious pricing fight.

March 28, 2019
·
2 min read
·
Alex Keown
Business

4 Big Real Estate Buys Benefit Bay Area Biotechs

With pharma and biotech companies fighting for elbow room in the Bay Area where space comes at a premium, it should come as no surprise that some companies are spending big bucks on the space they desire in one of the most vibrant pharma hubs in the world.

March 28, 2019
·
2 min read
·
Alex Keown
Deals

Probiodrug reports full year 2018 financial results

Probiodrug AG announced its financial results for the twelve-month period ending December 31, 2018, prepared in accordance with German GAAP and on a voluntary basis, in accordance with IFRS as endorsed by the European Union.

March 28, 2019
·
13 min read
Deals

InflaRx Full Year 2018 Financial & Operating Results

$62.9 million (€53.0 million) raised in a follow-on offering to advance clinical programs for IFX-1

March 28, 2019
·
13 min read
Orion Biotechnology to Present OB-002 in Vitro Potency Data at the 10th International AIDS Society HIV Science Meeting in Mexico City in July 2019

Orion Biotechnology Canada Ltd. announced that it will be presenting data on the potency of OB-002, their CCR5 antagonist currently in development for HIV prevention and oncology indications, at the 10th IAS HIV Science Meeting that will be held in Mexico City in July 2019.

March 28, 2019
·
3 min read
Job Trends

New potential therapeutic target for pancreatic cancer discovered

MD Anderson study demonstrates role of protein syndecan-1 in regulation of KRAS gene

March 28, 2019
·
5 min read
Business

Bristol-Myers Squibb and Concerto HealthAI Sign Cancer Real World Data Agreement

BMS inked a multi-year strategic agreement with Concerto HealthAI, which focuses on oncology-specific Real-World Data (RWD) and advanced AI for Real-World Evidence (RWE) generation.

March 28, 2019
·
3 min read
·
Mark Terry